Peptide-based therapeutics, especially GLP-1 agonists, have become essential tools in treating chronic diseases like type 2 diabetes and obesity
Physician monitored Low-dose, Physician guided Ongoing maintenance Physician guided subcutaneous injection Medication, clinician, follow-ups What you can expect TWO PATHWAYS
PlexusDx also offers oral semaglutide ($289/mo), microdose GLP-1 protocol ($129/mo for sensitive patients), and tirzepatide options for those seeking dual-peptide mechanisms
Ipamorelin, also believed by its experimental identifier NNC 26-0161, is a pentapeptide characterized by the amino acid sequence Aib-His-D-2-Nal-D-Phe-Lys-NH, which also interacts with the pituitary gland cells but via a different mechanism
The brand explicitly positions this as "a conversation-starter with your clinical team, not as a diagnostic document." That framing is important: it's a tool to make your clinical conversations more productive, not a replacement for those conversations
